The fast pace of drug discovery programs, aided by highthroughput screening campaigns, often relies on the generation of combinatorial libraries to identify new chemical entities. The Ugi 4-and 3-component reactions in particular [1] , have proven to be robust in producing both tool compounds and drugs [2, 3] . Here we report a high-throughput entry into the imidazopyridine scaffold, using a microfluidic-assisted synthesis setup, coupled to a target prediction tool to de-orphan a focused compound library with high success rate, and identify an innovative GPCR-inhibiting chemotype. Combinatorial compounds were correctly identified as ligand-efficient adenosine A 1/2B , and adrenergic α 1A/B inhibitors with K i values in the low micromolar range.
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